These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36399131)

  • 1. Evaluating brain white matter hyperintensity, IQ scores, and plasma neurofilament light chain concentration in early-treated patients with infantile-onset Pompe disease.
    Hsu YK; Chien YH; Shinn-Forng Peng S; Hwu WL; Lee WT; Lee NC; Po-Yu Huang E; Weng WC
    Genet Med; 2023 Jan; 25(1):27-36. PubMed ID: 36399131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe CNS involvement in a subset of long-term treated children with infantile-onset Pompe disease.
    Kenney-Jung D; Korlimarla A; Spiridigliozzi GA; Wiggins W; Malinzak M; Nichting G; Jung SH; Sun A; Wang RY; Al Shamsi A; Phornphutkul C; Owens J; Provenzale JM; Kishnani PS
    Mol Genet Metab; 2024 Feb; 141(2):108119. PubMed ID: 38184429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofilament Light and Its Association With CNS Involvement in Patients With Classic Infantile Pompe Disease.
    Mackenbach MJ; Willemse EAJ; van den Dorpel JJA; van der Beek NAME; Díaz-Manera J; Rizopoulos D; Teunissen C; van der Ploeg AT; van den Hout JMP
    Neurology; 2023 Aug; 101(6):e594-e601. PubMed ID: 37336766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel approaches to quantify CNS involvement in children with Pompe disease.
    Korlimarla A; Spiridigliozzi GA; Crisp K; Herbert M; Chen S; Malinzak M; Stefanescu M; Austin SL; Cope H; Zimmerman K; Jones H; Provenzale JM; Kishnani PS
    Neurology; 2020 Aug; 95(6):e718-e732. PubMed ID: 32518148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion tensor imaging of the brain in Pompe disease.
    van den Dorpel JJA; Dremmen MHG; van der Beek NAME; Rizopoulos D; van Doorn PA; van der Ploeg AT; Muetzel RL; van den Hout JMP
    J Neurol; 2023 Mar; 270(3):1662-1671. PubMed ID: 36480052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentric Retrospective Evaluation of Five Classic Infantile Pompe Disease Subjects Under Enzyme Replacement Therapy With Early Infratentorial Involvement.
    Paoletti M; Pichiecchio A; Colafati GS; Conte G; Deodato F; Gasperini S; Menni F; Furlan F; Rubert L; Triulzi FM; Cinnante C
    Front Neurol; 2020; 11():569153. PubMed ID: 33329311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classic infantile Pompe patients approaching adulthood: a cohort study on consequences for the brain.
    Ebbink BJ; Poelman E; Aarsen FK; Plug I; Régal L; Muentjes C; van der Beek NAME; Lequin MH; van der Ploeg AT; van den Hout JMP
    Dev Med Child Neurol; 2018 Jun; 60(6):579-586. PubMed ID: 29573408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcome of Infantile Onset Pompe Disease Patients Treated with Enzyme Replacement Therapy - Data from a German-Austrian Cohort.
    Pfrimmer C; Smitka M; Muschol N; Husain RA; Huemer M; Hennermann JB; Schuler R; Hahn A
    J Neuromuscul Dis; 2024; 11(1):167-177. PubMed ID: 38043017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum neurofilament light chain correlates with myelin and axonal magnetic resonance imaging markers in multiple sclerosis.
    Yik JT; Becquart P; Gill J; Petkau J; Traboulsee A; Carruthers R; Kolind SH; Devonshire V; Sayao AL; Schabas A; Tam R; Moore GRW; Li DKB; Stukas S; Wellington C; Quandt JA; Vavasour IM; Laule C
    Mult Scler Relat Disord; 2022 Jan; 57():103366. PubMed ID: 35158472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term clinical history of an Italian cohort of infantile onset Pompe disease treated with enzyme replacement therapy.
    Parini R; De Lorenzo P; Dardis A; Burlina A; Cassio A; Cavarzere P; Concolino D; Della Casa R; Deodato F; Donati MA; Fiumara A; Gasperini S; Menni F; Pagliardini V; Sacchini M; Spada M; Taurisano R; Valsecchi MG; Di Rocco M; Bembi B
    Orphanet J Rare Dis; 2018 Feb; 13(1):32. PubMed ID: 29422078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter lesions in treated late onset Pompe disease are not different to matched controls.
    Schneider I; Hensel O; Zierz S
    Mol Genet Metab; 2019 Jun; 127(2):128-131. PubMed ID: 31153821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slow, progressive myopathy in neonatally treated patients with infantile-onset Pompe disease: a muscle magnetic resonance imaging study.
    Peng SS; Hwu WL; Lee NC; Tsai FJ; Tsai WH; Chien YH
    Orphanet J Rare Dis; 2016 May; 11(1):63. PubMed ID: 27183828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofilament light chain and glial fibrillary acidic protein levels in metachromatic leukodystrophy.
    Beerepoot S; Heijst H; Roos B; Wamelink MMC; Boelens JJ; Lindemans CA; van Hasselt PM; Jacobs EH; van der Knaap MS; Teunissen CE; Wolf NI
    Brain; 2022 Mar; 145(1):105-118. PubMed ID: 34398223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma neurofilament light levels correlate with white matter damage prior to Alzheimer's disease: results from ADNI.
    Nabizadeh F; Balabandian M; Rostami MR; Kankam SB; Ranjbaran F; Pourhamzeh M;
    Aging Clin Exp Res; 2022 Oct; 34(10):2363-2372. PubMed ID: 35226303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Airway abnormalities in very early treated infantile-onset Pompe disease: A large-scale survey by flexible bronchoscopy.
    Yang CF; Niu DM; Tai SK; Wang TH; Su HT; Huang LY; Soong WJ
    Am J Med Genet A; 2020 Apr; 182(4):721-729. PubMed ID: 31953985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term survival in patients with classic infantile Pompe disease reveals a spectrum with progressive brain abnormalities and changes in cognitive functioning.
    van den Dorpel JJA; Mackenbach MJ; Dremmen MHG; van der Vlugt WMC; Rizopoulos D; van Doorn PA; van der Ploeg AT; Muetzel R; van der Beek NAME; van den Hout JMP
    J Inherit Metab Dis; 2024 Apr; ():. PubMed ID: 38584574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroimaging findings in infantile Pompe patients treated with enzyme replacement therapy.
    McIntosh PT; Hobson-Webb LD; Kazi ZB; Prater SN; Banugaria SG; Austin S; Wang R; Enterline DS; Frush DP; Kishnani PS
    Mol Genet Metab; 2018 Feb; 123(2):85-91. PubMed ID: 29050825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metachromatic leukodystrophy: natural course of cerebral MRI changes in relation to clinical course.
    Groeschel S; Kehrer C; Engel C; I Dali C; Bley A; Steinfeld R; Grodd W; Krägeloh-Mann I
    J Inherit Metab Dis; 2011 Oct; 34(5):1095-102. PubMed ID: 21698385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease.
    Schultz SA; Strain JF; Adedokun A; Wang Q; Preische O; Kuhle J; Flores S; Keefe S; Dincer A; Ances BM; Berman SB; Brickman AM; Cash DM; Chhatwal J; Cruchaga C; Ewers M; Fox NN; Ghetti B; Goate A; Graff-Radford NR; Hassenstab JJ; Hornbeck R; Jack C; Johnson K; Joseph-Mathurin N; Karch CM; Koeppe RA; Lee AKW; Levin J; Masters C; McDade E; Perrin RJ; Rowe CC; Salloway S; Saykin AJ; Sperling R; Su Y; Villemagne VL; Vöglein J; Weiner M; Xiong C; Fagan AM; Morris JC; Bateman RJ; Benzinger TLS; Jucker M; Gordon BA;
    Neurobiol Dis; 2020 Aug; 142():104960. PubMed ID: 32522711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the brain involved in patients with late-onset Pompe disease?
    van den Dorpel JJA; van der Vlugt WMC; Dremmen MHG; Muetzel R; van den Berg E; Hest R; de Kriek J; Brusse E; van Doorn PA; van der Ploeg AT; van den Hout JMP; van der Beek NAME
    J Inherit Metab Dis; 2022 May; 45(3):493-501. PubMed ID: 34927739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.